Does lowering blood pressure below 120 help people with diabetes? Explore OPTIMAL-DIABETES findings on heart outcomes, kidney risks, and treatment goals.
Read More »Salt and the Diabetic Kidney: Are Early Warning Signs Appearing Before Overt Damage?
Explore how higher salt intake may be linked to early kidney damage in older adults with type 2 diabetes and why kidney screening matters.
Read More »Normal UACR, Declining Kidneys: The Blind Spot These Biomarkers May Expose
Discover how emerging kidney biomarkers may identify kidney decline in people with type 2 diabetes despite normal UACR levels.
Read More »The SGLT2 Hemoglobin Effect: A Clue to Cardiorenal Protection?
Learn how SGLT2 inhibitors affect hemoglobin and hematocrit, and what a JAMA meta-analysis reveals about possible heart and kidney benefits.
Read More »Can Better Self-Management Protect the Kidneys Before Damage Takes Hold?
Can better diabetes self-management protect kidney health? Explore new trial findings on A1C, blood pressure, cholesterol, and kidney function.
Read More »Metformin Before the ICU: A Surprising Kidney Signal Challenges the Usual Narrative
A new ICU study links prior metformin use to lower odds of acute kidney injury. Explore the findings, limitations, and implications for diabetes care.
Read More »Quit Smoking, Protect More Than Your Heart: When Diabetes Complication Risk Starts to Fall
New research links smoking cessation to lower diabetes complication risks. Explore what the findings mean for kidney, eye, and nerve health.
Read More »SGLT Inhibitors Protect the Heart and Kidneys: Why Is Type 1 Diabetes Still the Exception?
SGLT inhibitors have changed the treatment landscape for cardiovascular and kidney disease, particularly in people with type 2 diabetes, heart failure, and chronic kidney disease. That success raises an obvious question: why are SGLT inhibitors in type 1 diabetes still largely outside routine clinical practice? The answer is not a …
Read More »Dialysis Changes the Rules: What Happens When Patients With Diabetes Use Real-Time CGM?
Managing glucose is rarely simple for people with Type 2 diabetes who receive maintenance hemodialysis. Dialysis can change glucose patterns, insulin needs, and the reliability of familiar measures such as A1C. As a result, clinicians may have an incomplete picture when making treatment decisions. New randomized research on CGM use …
Read More »Your Eye Exam May Be Predicting More Than Vision Loss: AI Is Finding Hidden Diabetes Risks
For people with diabetes, a retinal photograph has traditionally answered one major question: Is diabetic retinopathy developing? However, artificial intelligence is beginning to uncover much more. Emerging retinal AI models for systemic risk assessment can detect patterns associated with cardiovascular disease, kidney disease, blood pressure, and metabolic health. As a …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.